Bayer

  • Bayer Wins US Legal Victory Against Roundup Cancer Claims; Shares Surge

    Bayer (BAYGn.DE) won a significant legal victory in its ongoing effort to limit liability from claims that its Roundup weed killer causes cancer. On Thursday, a U.S. appeals court ruled that federal law protects the German company from a lawsuit filed by a Pennsylvania landscaper. Following the decision, Bayer’s shares surged as much as 13.2%…

  • Judge Cuts Bayer $2.25 Billion Roundup Verdict To $400 Million

    On Tuesday, a Pennsylvania judge reduced a $2.25 billion U.S. verdict against Bayer (BAYGn.DE) to $400 million. This decision involved a Pennsylvania man, John McKivison, who claimed he developed cancer from exposure to the company’s Roundup weedkiller. A jury in the Philadelphia Court of Common Pleas determined that McKivison’s non-Hodgkins lymphoma resulted from using Roundup…

  • Judge Slashes Bayer $1.56 Billion Roundup Verdict To $611 Million

    A Missouri judge has significantly reduced a $1.56 billion verdict against Bayer, cutting it down to $611 million for three plaintiffs who alleged that the company’s Roundup weed killer caused their cancer. The reduction in punitive damages was the primary reason behind this adjustment, with Bayer promptly announcing its intention to appeal the decision. The…